GGrantIndex
Sort

53,477 grants matching addiction

Virtual systemic identification of drug targets of obesity candidate genes

$661,107
Yingchang Lu · Vanderbilt University Medical Center · R01 · FY2025 · DK

Endocannabinoid roles in neurochemical and reinforcing effects of abused drugs

$661,086
Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2019 · DA

The impact of electronic cigarettes (e-cigs) on perinatal immune responsiveness and birth outcomes in Appalachia

$661,043
Kristin H. Ashford · University Of Kentucky · R01 · FY2017 · DA

Scientific Core

$661,014
Amelia M Arria · Treatment Research Institute · P50 · FY2014 · DA

Drug Abuse: Discovering Ligands for Pertinent GPCRs

$660,956
Marc G. Caron · Duke University · P30 · FY2014 · DA

Melanoma Resistance Evolution Atlas (MREA) for identifying combinatorial targets to prevent and reverse MAPKi resistance

$660,833
Roger S Lo · University Of California Los Angeles · R01 · FY2024 · CA

TRANSCRIPTOME AND EPIGENOME MAPPING IN DOPAMINE NEURONS FROM THE OPIOID EXPOSED HUMAN BRAIN

$660,805
Schahram Akbarian · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DA

Anhedonia as a Risk Factor and Consequence of Substance Use

$660,682
Adam Matthew Leventhal · University Of Southern California · R01 · FY2013 · DA

Mindful Moms in Recovery: Yoga-based mindfulness relapse prevention for pregnant women with opioid disorder

$660,648
Sarah E Lord · Dartmouth College · R33 · FY2020 · AT

Very Low-Nicotine Cigarettes in Smokers with SUD: Smoking, Substance Use Effects

$660,626
Damaris J. Rohsenow · Brown University · R01 · FY2013 · DA

Cannabinergic Medications for Methamphetamine Addiction

$660,516
Alexandros Makriyannis · Northeastern University · R37 · FY2011 · DA

Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications, and CBT4CBT: A randomized clinical trial in a diverse patient population

$660,449
E. Jennifer Edelman · Yale University · R01 · FY2025 · AA

Prison Interventions and HIV Prevention Collaboration

$660,401
Frederick Lewis Altice · Yale University · R01 · FY2017 · DA

Prison Interventions and HIV Prevention Collaboration

$660,401
Frederick Lewis Altice · Yale University · R01 · FY2019 · DA

Manipulating Tobacco Constituents in Female Menthol Smokers

$660,359
Cheryl Oncken · University Of Connecticut Sch Of Med/Dnt · R01 · FY2014 · DA

Prefrontal Function in Adolescent Limited vs Life Course Persistent SUD

$660,339
Michael Damingo De Bellis · Duke University · R01 · FY2011 · DA

Functional genomic resource and integrative model of dopaminergic circuitry associated with psychiatric disease

$660,307
Schahram Akbarian · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · DA

Functional genomic resource and integrative model of dopaminergic circuitry associated with psychiatric disease

$660,307
Schahram Akbarian · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · DA

Implementation, reach, and impact of court-ordered tobacco corrective statement postings at the point-of-sale

$660,281
Olivia Wackowski · Rutgers Biomedical And Health Sciences · R33 · FY2025 · CA

ANALYSIS OF TOBACCO INDUSTRY DOCUMENTS

$660,256
University Of California San Francisco · R01 · FY2003 · CA

TREATMENT AND OUTCOME OF EARLY ONSET BIPOLAR DISORDER

$660,209
Feinstein Institute For Medical Research · R01 · FY2003 · MH

CT Research Center for Criminal Justice Drug Abuse Treatment Study Center

$660,205
Linda K Frisman · University Of Connecticut Storrs · U01 · FY2010 · DA

Socio-moral processing in psychopathy and substance abuse

$660,196
Kent A Kiehl · The Mind Research Network · R01 · FY2011 · DA

Targeting System Xc- for the Treatment of Addiction

$660,133
David A Baker · Marquette University · R01 · FY2010 · DA

Influence of 5-HT1b Activation on the Abuse Related Effects of Cocaine

$660,131
William Walton Stoops · University Of Kentucky · R01 · FY2022 · DA